HAS is characterized by a histological resemblance to hepatocellular carcinoma (HCC); in addition to morphological confirmation, HAS can be confirmed by several immunohistochemical markers, such as AFP, GPC-3, SALL4, and Hap-Par 1 [4, 5]. The gene discussed is SALL4; the disease is hepatocellular carcinoma.